US Stock MarketDetailed Quotes

Zevra Therapeutics (ZVRA)

Watchlist
  • 11.250
  • +0.640+6.03%
Close May 6 16:00 ET
  • 11.280
  • +0.030+0.27%
Post 20:01 ET
665.04MMarket Cap8.33P/E (TTM)

Zevra Therapeutics (ZVRA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
350.91%106.47M
183.36%34.13M
605.36%26.06M
481.73%25.88M
495.65%20.4M
-14.02%23.61M
-6.79%12.04M
27.63%3.7M
-47.47%4.45M
7.84%3.43M
Operating revenue
350.91%106.47M
183.36%34.13M
605.36%26.06M
481.73%25.88M
495.65%20.4M
-14.02%23.61M
-6.79%12.04M
27.63%3.7M
-47.47%4.45M
7.84%3.43M
Cost of revenue
122.22%16.48M
11.27%1.52M
-46.24%1.24M
246.46%12.38M
668.57%1.35M
241.33%7.42M
11.33%1.37M
1,499.31%2.3M
427.77%3.57M
40.00%175K
Gross profit
455.65%89.99M
205.38%32.61M
1,683.41%24.83M
1,441.32%13.5M
486.34%19.06M
-35.96%16.2M
-8.69%10.68M
-49.40%1.39M
-88.76%876K
6.52%3.25M
Operating expense
-8.70%94.22M
-10.74%23.29M
-27.93%20.68M
4.70%25.83M
2.87%24.42M
37.80%103.2M
-2.82%26.09M
58.42%28.7M
75.66%24.67M
49.45%23.74M
Selling and administrative expenses
41.46%77.62M
26.23%20.35M
4.49%16.94M
64.88%20.78M
96.81%19.55M
59.90%54.87M
10.02%16.13M
178.58%16.21M
90.62%12.6M
37.42%9.93M
Research and development costs
-69.73%12.74M
-68.63%2.62M
-68.64%3.43M
-67.37%3.43M
-73.46%3.26M
5.75%42.1M
-26.87%8.35M
-10.99%10.95M
41.54%10.52M
41.85%12.28M
Depreciation amortization depletion
-38.06%3.86M
-80.45%316K
-79.61%315K
4.53%1.62M
5.69%1.62M
707.64%6.24M
109.33%1.62M
--1.55M
--1.55M
--1.53M
-Depreciation and amortization
-38.06%3.86M
-80.45%316K
-79.61%315K
4.53%1.62M
5.69%1.62M
707.64%6.24M
109.33%1.62M
--1.55M
--1.55M
--1.53M
Operating profit
95.13%-4.23M
160.42%9.32M
115.17%4.14M
48.19%-12.33M
73.83%-5.36M
-75.40%-87M
-1.71%-15.42M
-77.73%-27.31M
-280.60%-23.8M
-59.66%-20.49M
Net non-operating interest income expense
80.08%-1.03M
89.59%-236K
120.74%262K
120.05%369K
-835.05%-1.43M
-270.26%-5.18M
-315.20%-2.27M
-192.06%-1.26M
-235.69%-1.84M
-77.44%194K
Non-operating interest income
219.36%6.95M
2,445.21%1.71M
120.50%2.31M
780.74%2.38M
-41.55%543K
-52.10%2.18M
-134.76%-73K
-39.64%1.05M
-82.61%270K
-10.84%929K
Non-operating interest expense
8.52%7.98M
-11.21%1.95M
-11.29%2.05M
-4.79%2.01M
167.89%1.97M
389.74%7.35M
190.21%2.19M
531.69%2.31M
971.07%2.11M
303.85%735K
Other net income (expense)
4,409.17%91.94M
233.59%3.59M
-15.59%-5.38M
1,437.47%88.87M
35.31%4.87M
295.92%2.04M
35.90%-2.69M
-222.46%-4.66M
157.00%5.78M
366.86%3.6M
Gain on sale of security
14.12%2.33M
233.59%3.59M
-15.59%-5.38M
-112.96%-749K
35.31%4.87M
295.92%2.04M
35.90%-2.69M
-222.46%-4.66M
157.00%5.78M
366.86%3.6M
Special income (charges)
--89.62M
--0
--0
--89.62M
----
--0
--0
--0
--0
----
-Less:Impairment of capital assets
--58.71M
--0
--0
--58.71M
----
--0
--0
--0
--0
----
-Gain on sale of property,plant,equipment
--148.33M
--0
--0
--148.33M
----
--0
--0
--0
--0
----
Income before tax
196.16%86.68M
162.19%12.67M
97.06%-977K
487.34%76.91M
88.52%-1.92M
-95.75%-90.14M
-2.39%-20.37M
-226.05%-33.23M
-650.09%-19.86M
-25.32%-16.69M
Income tax
-77.56%3.45M
-96.74%501K
-433K
3,041.43%2.2M
1,788.57%1.18M
15.37M
15.37M
0
194.59%70K
32.04%-70K
Net income
178.88%83.23M
134.04%12.17M
98.36%-544K
474.94%74.71M
81.36%-3.1M
-129.13%-105.51M
-79.67%-35.74M
-220.49%-33.23M
-674.39%-19.93M
-25.76%-16.62M
Net income continuous Operations
178.88%83.23M
134.04%12.17M
98.36%-544K
474.94%74.71M
81.36%-3.1M
-129.13%-105.51M
-79.67%-35.74M
-220.49%-33.23M
-674.39%-19.93M
-25.76%-16.62M
Minority interest income
Net income attributable to the parent company
178.88%83.23M
134.04%12.17M
98.36%-544K
474.94%74.71M
81.36%-3.1M
-129.13%-105.51M
-79.67%-35.74M
-220.49%-33.23M
-674.39%-19.93M
-25.76%-16.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
178.88%83.23M
134.04%12.17M
98.36%-544K
474.94%74.71M
81.36%-3.1M
-129.13%-105.51M
-79.67%-35.74M
-220.49%-33.23M
-674.39%-19.93M
-25.76%-16.62M
Basic earnings per share
161.40%1.4
128.99%0.2
98.55%-0.01
358.33%1.24
85.00%-0.06
-75.38%-2.28
-27.78%-0.69
-130.00%-0.69
-500.00%-0.48
-5.26%-0.4
Diluted earnings per share
159.21%1.35
127.54%0.19
98.55%-0.01
352.08%1.21
85.00%-0.06
-75.38%-2.28
-27.78%-0.69
-130.00%-0.69
-500.00%-0.48
-5.26%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 350.91%106.47M183.36%34.13M605.36%26.06M481.73%25.88M495.65%20.4M-14.02%23.61M-6.79%12.04M27.63%3.7M-47.47%4.45M7.84%3.43M
Operating revenue 350.91%106.47M183.36%34.13M605.36%26.06M481.73%25.88M495.65%20.4M-14.02%23.61M-6.79%12.04M27.63%3.7M-47.47%4.45M7.84%3.43M
Cost of revenue 122.22%16.48M11.27%1.52M-46.24%1.24M246.46%12.38M668.57%1.35M241.33%7.42M11.33%1.37M1,499.31%2.3M427.77%3.57M40.00%175K
Gross profit 455.65%89.99M205.38%32.61M1,683.41%24.83M1,441.32%13.5M486.34%19.06M-35.96%16.2M-8.69%10.68M-49.40%1.39M-88.76%876K6.52%3.25M
Operating expense -8.70%94.22M-10.74%23.29M-27.93%20.68M4.70%25.83M2.87%24.42M37.80%103.2M-2.82%26.09M58.42%28.7M75.66%24.67M49.45%23.74M
Selling and administrative expenses 41.46%77.62M26.23%20.35M4.49%16.94M64.88%20.78M96.81%19.55M59.90%54.87M10.02%16.13M178.58%16.21M90.62%12.6M37.42%9.93M
Research and development costs -69.73%12.74M-68.63%2.62M-68.64%3.43M-67.37%3.43M-73.46%3.26M5.75%42.1M-26.87%8.35M-10.99%10.95M41.54%10.52M41.85%12.28M
Depreciation amortization depletion -38.06%3.86M-80.45%316K-79.61%315K4.53%1.62M5.69%1.62M707.64%6.24M109.33%1.62M--1.55M--1.55M--1.53M
-Depreciation and amortization -38.06%3.86M-80.45%316K-79.61%315K4.53%1.62M5.69%1.62M707.64%6.24M109.33%1.62M--1.55M--1.55M--1.53M
Operating profit 95.13%-4.23M160.42%9.32M115.17%4.14M48.19%-12.33M73.83%-5.36M-75.40%-87M-1.71%-15.42M-77.73%-27.31M-280.60%-23.8M-59.66%-20.49M
Net non-operating interest income expense 80.08%-1.03M89.59%-236K120.74%262K120.05%369K-835.05%-1.43M-270.26%-5.18M-315.20%-2.27M-192.06%-1.26M-235.69%-1.84M-77.44%194K
Non-operating interest income 219.36%6.95M2,445.21%1.71M120.50%2.31M780.74%2.38M-41.55%543K-52.10%2.18M-134.76%-73K-39.64%1.05M-82.61%270K-10.84%929K
Non-operating interest expense 8.52%7.98M-11.21%1.95M-11.29%2.05M-4.79%2.01M167.89%1.97M389.74%7.35M190.21%2.19M531.69%2.31M971.07%2.11M303.85%735K
Other net income (expense) 4,409.17%91.94M233.59%3.59M-15.59%-5.38M1,437.47%88.87M35.31%4.87M295.92%2.04M35.90%-2.69M-222.46%-4.66M157.00%5.78M366.86%3.6M
Gain on sale of security 14.12%2.33M233.59%3.59M-15.59%-5.38M-112.96%-749K35.31%4.87M295.92%2.04M35.90%-2.69M-222.46%-4.66M157.00%5.78M366.86%3.6M
Special income (charges) --89.62M--0--0--89.62M------0--0--0--0----
-Less:Impairment of capital assets --58.71M--0--0--58.71M------0--0--0--0----
-Gain on sale of property,plant,equipment --148.33M--0--0--148.33M------0--0--0--0----
Income before tax 196.16%86.68M162.19%12.67M97.06%-977K487.34%76.91M88.52%-1.92M-95.75%-90.14M-2.39%-20.37M-226.05%-33.23M-650.09%-19.86M-25.32%-16.69M
Income tax -77.56%3.45M-96.74%501K-433K3,041.43%2.2M1,788.57%1.18M15.37M15.37M0194.59%70K32.04%-70K
Net income 178.88%83.23M134.04%12.17M98.36%-544K474.94%74.71M81.36%-3.1M-129.13%-105.51M-79.67%-35.74M-220.49%-33.23M-674.39%-19.93M-25.76%-16.62M
Net income continuous Operations 178.88%83.23M134.04%12.17M98.36%-544K474.94%74.71M81.36%-3.1M-129.13%-105.51M-79.67%-35.74M-220.49%-33.23M-674.39%-19.93M-25.76%-16.62M
Minority interest income
Net income attributable to the parent company 178.88%83.23M134.04%12.17M98.36%-544K474.94%74.71M81.36%-3.1M-129.13%-105.51M-79.67%-35.74M-220.49%-33.23M-674.39%-19.93M-25.76%-16.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 178.88%83.23M134.04%12.17M98.36%-544K474.94%74.71M81.36%-3.1M-129.13%-105.51M-79.67%-35.74M-220.49%-33.23M-674.39%-19.93M-25.76%-16.62M
Basic earnings per share 161.40%1.4128.99%0.298.55%-0.01358.33%1.2485.00%-0.06-75.38%-2.28-27.78%-0.69-130.00%-0.69-500.00%-0.48-5.26%-0.4
Diluted earnings per share 159.21%1.35127.54%0.1998.55%-0.01352.08%1.2185.00%-0.06-75.38%-2.28-27.78%-0.69-130.00%-0.69-500.00%-0.48-5.26%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More